Acquisitions often lead to an increase in a company's stock price, especially if the acquisition has the potential to expand the company's product portfolio and market reach. In this case, Eyenovia's acquisition of the commercial rights to APP13007, a treatment for post ocular surgery pain and inflammation, could potentially expand its product portfolio and market reach, which may positively impact its stock price in the short term.